Ignite Creation Date:
2025-12-25 @ 12:12 AM
Ignite Modification Date:
2025-12-25 @ 10:13 PM
Study NCT ID:
NCT05360758
Status:
UNKNOWN
Last Update Posted:
2022-12-28
First Post:
2022-04-27
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Ibrutinib Adapted to Response in Patients With CLL
Sponsor:
Grupo Argentino de Tratamiento de la Leucemia Aguda
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
GATLA 11-LLC-21
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None